TYK MEDICINES: A shareholder holds 4.608 million non-listed shares converted to H shares, completing the filing with the China Securities Regulatory Commission

TYK MEDICINES-B (02410.HK) announced that recently, the China Securities Regulatory Commission has issued a filing notice to the company regarding the full circulation of H shares. The filing with the China Securities Regulatory Commission for the conversion of 4.608 million non-listed shares held by one shareholder into the same number of H shares has been completed.

Upon completion of the conversion and the approval for listing granted by the Stock Exchange of Hong Kong, these 4.608 million H shares will be listed and traded on the main board of the Stock Exchange. The filing notice will be valid for 12 months from the date of approval by the China Securities Regulatory Commission. The details of the implementation plan for the full circulation of H shares have not yet been finalized